- Chikungunya vaccine developed by Butantan is safe and generates sustained immune response in 96% of volunteers, study findsGZH
- Chikungunya vaccine is 96% effective, says ButantanLive well
- Rio Preto study attests to the effectiveness of the chikungunya vaccine in the United StatesNewspaper of the region
- Chikungunya vaccine generates immune response in 96% of volunteers, Butantan saysMetro1
- Butantan Releases Chikungunya Vaccine Test ResultsBrazil Television
- See full coverage on Google News
Chikungunya vaccine developed by Butantan is safe and generates sustained immune response in 96% of volunteers, study finds – GZH
